Measurement of lipoprotein(a) via a novel point of care approach with comparison to established laboratory assays
Point of care testing could be a complimentary option to laboratory testing of lipoprotein(a), especially in remote areas. It may help (re-)stratify cardiovascular risk and help tailor treatment decisions.
Authors
- Karam Kostner
- Andrew J. Kassianos (ORCID: https://orcid.org/0000-0002-0994-3588)
- Andy Liu (ORCID: https://orcid.org/0000-0003-3096-1788)
- Greg Ward
- Alex C Dechavez
- Chantelle Ebersohn
- Caroline A.E. Bachmeier
Institutions
- Mater Health Services (AU)
- The University of Queensland (AU)
- Royal Brisbane and Women's Hospital (AU)
- Douglass Hanly Moir Pathology (AU)
- Sullivan Nicolaides Pathology (AU)
- Mater Adult Hospital (AU)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2026-01-05
- DOI
- https://doi.org/10.1515/cclm-2025-1605
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Health and Medical Research Council